[Federal Register Volume 62, Number 136 (Wednesday, July 16, 1997)]
[Notices]
[Page 38056]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-18652]


      
 ========================================================================
 Notices
                                                 Federal Register
 ________________________________________________________________________
 
 This section of the FEDERAL REGISTER contains documents other than rules 
 or proposed rules that are applicable to the public. Notices of hearings 
 and investigations, committee meetings, agency decisions and rulings, 
 delegations of authority, filing of petitions and applications and agency 
 statements of organization and functions are examples of documents 
 appearing in this section.
 
 ========================================================================
 

  Federal Register / Vol. 62, No. 136 / Wednesday, July 16, 1997 / 
Notices  

[[Page 38056]]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control


Drug Control Research, Data, and Evaluation Committee; Meeting

AGENCY: Executive Office of the President, Office of National Drug 
Control Policy.

ACTION: The Drug Control Research, Data, and Evaluation Committee 
(DCRDEC); Notice of Forthcoming Meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a forthcoming meeting of the Drug 
Control Research, Data, and Evaluation Committee of the Office of 
National Drug Control Policy.
    Date, time and place. July 30, 1997, 9:00 a.m., Office of National 
Drug Control Policy (ONDCP), Executive Office of the President, 750 
17th Street, N.W., Washington, D.C.
    Type of meeting and contact person. Open public meeting, 10:00 a.m. 
to 2:00 p.m., unless public participation does not last that long; open 
committee discussion, 10:00 a.m. to 1:30 p.m.; Janie Dargan, ONDCP, 
(202) 395-6714. Persons intending to attend the meeting should arrive 
in advance and come to 7th Floor Security with identification; the 
meeting will take place on a secure floor of the building.
    General function of the committee. The Committee provides an avenue 
of communication by which a distinguished group of experts representing 
scientific, engineering, law enforcement, treatment, and associated 
international scientific communities advise the Director of the Office 
of National Drug Control Policy (ONDCP) on questions related to 
national drug control research. The Committee assists ONDCP in 
identifying gaps in current data collection to improve the generation 
of accurate and useful information on which to base national drug 
control policy.
    Agenda--Open public meeting. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the Committee. Specifically, the Committee will provide input into 
recommendations made to ONDCP by an independent group of drug research 
experts on how to better integrate information and drug control policy. 
Additionally, the Committee will advise ONDCP on major policy 
initiatives and data priorities. Those desiring to make a formal 
presentation should notify the contact person before July 23, 1997, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time required to 
make their comments.
    Open committee discussion. The Committee will discuss and advise 
ONDCP regarding the following:

--Federal Drug-Related Data Needs
--the Integration of Information and Drug Control Policy
--Future Needs for Prevention and Treatment Research
--Harnessing Technology to Support the National Drug Control Strategy

    The agenda, the questions to be addressed by the committee, and a 
current list of committee members will be available at the meeting 
location on the day of the meeting. Transcripts of the open portion of 
the meeting may be requested in writing from the Executive Office of 
the President, Office of National Drug Control Policy, FOIA Requests, 
Office of Legal Counsel, 750 17th Street, N.W., Washington, D.C. 20503, 
approximately 15 working days after the meeting, at a cost of 10 cents 
per page. The transcript may be viewed at the Office of National Drug 
Control Policy, Office of Legal Counsel at the above indicated address. 
Summary minutes of the open portion of the meeting may be requested in 
writing from the Freedom of Information Office (address above) 
beginning approximately 90 days after the meeting.
    This notice is issued under section 10(a)(1) and (a)(2) of the 
Federal Advisory Committee Act (5 U.S.C. app. 2), and 41 CFR 101-6, et 
seq., the Federal regulations on advisory committee meetings.
Edward H. Jurith,
General Counsel.
[FR Doc. 97-18652 Filed 7-15-97; 8:45 am]
BILLING CODE 3180-02-P